Related Experiment Video
Updated: Jun 23, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Pneumococcal vaccines for allergic airways diseases
Alison N Thorburn1, Philip M Hansbro, Peter G Gibson
1The University of Newcastle, Hunter Medical Research Institute, Centre for Asthma and Respiratory Disease, Newcastle, Australia.
Pneumococcal infection may protect against asthma by modulating allergic airway responses. Further research is needed to explore pneumococcal immunoregulatory therapy for asthma management.
Area of Science:
- Immunology
- Allergy
- Respiratory Medicine
Background:
- Asthma is a prevalent global respiratory condition.
- Environmental factors, including bacterial exposure, may offer protection against asthma development.
Purpose of the Study:
- To review the potential protective effects of pneumococcal infection and vaccination in asthma.
- To explore the immunomodulatory mechanisms involved.
Main Methods:
- Comprehensive literature review of experimental biology and human epidemiology.
- Analysis of studies linking asthma and pneumococcal infection.
Main Results:
- Pneumococcal infection can alter key asthma indicators like airway hyperresponsiveness and eosinophilia.
- Exposure to inactivated pneumococcus demonstrates similar modulatory effects.
- The mechanism appears to involve the action of T regulatory cells.
Conclusions:
- Pneumococcal immunoregulatory therapy presents a promising avenue for asthma management.
- Further rigorous research is essential to validate its efficacy and safety.
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Pneumonia III: Complications and Assessment
